Dolutegravir

Dolutegravir/Rilpivirine Combination Drug Market Dolutegravir/rilpivirine is the first two-drug single-tablet regimen (STR) to be approved for the treatment of HIV-1 infection in adults. According to this study, over the next…

Dolutegravir and Its Combination Drug Market Dolutegravir (DTG), sold under the brand name Tivicay, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS.  Dolutegravir may also be used, as part of post exposure…